MDR-TB (multidrug-resistant tuberculosis)

Tuberculosis related lethality structure in Kharkiv, Ukraine: impact of COVID 19
O Konstantynovska, P Poteiko, T Synenko, O Stepanov, O Zinenko, T Liadova, O Volobuieva

European Respiratory Journal Sep 2022, 60 (suppl 66) 2492; DOI: 10.1183/13993003.congress-2022.2492
Usage of silver nanoparticles to restore Moxifloxacin efficacy for fluoroquinolone-resistant M.tuberculosis cultures.
T Avaliani, N Kiria, N Bablishvili, N Kiria, G Phichkhaia

European Respiratory Journal Sep 2022, 60 (suppl 66) 1592; DOI: 10.1183/13993003.congress-2022.1592
Mathematical model for predicting the treatment effectiveness of MDR-TB based on Human-beta-defensin-1 level
O Pogorelova, O Shevchenko, I Ovcharenko, O Hovardovska, O Shvets

European Respiratory Journal Sep 2022, 60 (suppl 66) 1278; DOI: 10.1183/13993003.congress-2022.1278
Cannabis and negative tuberculosis treatment outcomes association: a systematic review and meta-analysis
M Arangoitia Fernandez Baca, D Bustamante, F Cuti, P Ruiz-Grosso, C Ugarte-Gil

European Respiratory Journal Sep 2022, 60 (suppl 66) 1354; DOI: 10.1183/13993003.congress-2022.1354
Study of rifampicin and silver nanoparticle composite efficacy on rifampicin-resistant Mycobacterium tuberculosis strains
N Kiria, T Avaliani, N Bablishvili, N Kiria, G Phichkhaia

European Respiratory Journal Sep 2022, 60 (suppl 66) 1198; DOI: 10.1183/13993003.congress-2022.1198
Priority identification in the clinical case management of multidrug resistant Tuberculosis (MDR-TB) in Bangladesh
F Zaman, M Asaduzzaman

European Respiratory Journal Sep 2022, 60 (suppl 66) 1122; DOI: 10.1183/13993003.congress-2022.1122
Variability of resistance of Mycobacterium tuberculosis based on whole genome sequencing in patients with MDR and XDR-TB in the Kharkiv region,Ukraine
T Butova, M Kuzhko, O Solodiankin, N Rudova, A Tkachenko, D Butov, M Harris, A Gabrielian, D Hurt, A Rosenthal

European Respiratory Journal Sep 2022, 60 (suppl 66) 437; DOI: 10.1183/13993003.congress-2022.437
Mutational profile of gyrA and gyrB genes associated with fluoroquinolones (FQs) resistance among drug resistant tuberculosis patients: an observational study
V Bajiya, C R Choudhary, G Purohit, A Kuwal, A Mohanty

European Respiratory Journal Sep 2022, 60 (suppl 66) 68; DOI: 10.1183/13993003.congress-2022.68
Factors associated with sputum culture conversion in patients with multidrug-resistant tuberculosis
G Musteikiene, S Miliauskas

European Respiratory Journal Sep 2022, 60 (suppl 66) 343; DOI: 10.1183/13993003.congress-2022.343
Adenosine-regulated mechanisms in the pathogenesis of ventilation disorders in patients with pulmonary tuberculosis
Larisa Kiryukhina, Marina Dyakova, Nataliia Serebryanaya, Dilyara Esmedlyaeva, Piotr Yablonskii

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3611; DOI: 10.1183/13993003.congress-2021.PA3611

Main menu

User menu

Search

MDR-TB (multidrug-resistant tuberculosis)

Pages

Contact us